Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
---|
11/15/2012 | US20120289529 Combinations of trospium and salivary stimulants for the treatment of overactive bladder |
11/15/2012 | US20120289522 Compounds as lysophosphatidic acid receptor antagonists |
11/15/2012 | US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same |
11/15/2012 | US20120289505 Inhibitors of diacylglycerol acyl transferase |
11/15/2012 | US20120289504 Benzoimidazole Compounds and Uses Thereof |
11/15/2012 | US20120289496 Novel compounds as modulators of protein kinases |
11/15/2012 | US20120289457 Peptide oligonucleotide conjugates |
11/15/2012 | US20120289452 Compositions and methods for treating and preventing necrosis |
11/15/2012 | US20120288573 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders |
11/15/2012 | US20120288572 Multichamber container for preparing medicinal solutions |
11/15/2012 | US20120288561 Delayed-release formulation for reducing the frequency of urination and method of use thereof |
11/15/2012 | US20120288507 Wise binding agents and epitopes |
11/15/2012 | US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof |
11/15/2012 | CA2835279A1 Combinations of trospium and salivary stimulants for the treatment of overactive bladder |
11/15/2012 | CA2835277A1 Combinations of solifenacin and salivary stimulants for the treatment of overactive bladder |
11/14/2012 | EP2521724A2 Agents and methods for treating ischemic and other diseases |
11/14/2012 | EP2521716A2 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
11/14/2012 | CN102776101A Mung bean spirit prepared from crystal sugar |
11/14/2012 | CN102776095A Mulberry wine and preparation method thereof |
11/14/2012 | CN102775350A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
11/14/2012 | CN102772738A Superfine powder traditional Chinese medicine for hepatorenal protection of livestock and preparation method thereof |
11/14/2012 | CN102772731A Traditional Chinese medicine used for treating spleen-kidney yang deficiency-type chronic nephritis |
11/14/2012 | CN102772726A Kidney-warming and urination-reducing tablet |
11/14/2012 | CN102772697A Traditional Chinese medicine for treating Qi-Yin deficiency-type chronic nephritis |
11/14/2012 | CN102772680A Traditional Chinese medicine decoction used for treating chronic nephritis by using ginseng |
11/14/2012 | CN102772679A Chinese herbal preparation for treating chronic glomerulonephritis by tonifying yang |
11/14/2012 | CN102772661A Traditional Chinese medicinal composition for treating nephrolithiasis |
11/14/2012 | CN102772656A Semen cuscutae-rhizoma polygonati tablets |
11/14/2012 | CN102772556A Pathogenic fire and toxin clearing tablet |
11/14/2012 | CN102772499A Effective parts obtained by alcohol extraction of raw materials of Relingqing granules as well as preparation method and applications thereof |
11/14/2012 | CN102772497A Alcohol extraction effective part of medicinal material of Relinqing granules and preparation method thereof |
11/14/2012 | CN102772484A Decoction medicine for treating lung function dispersing and descending type proteinuria |
11/14/2012 | CN102772453A Turpinia formosana Nakai leaf ethanol backflow extract and preparation method and applications thereof |
11/14/2012 | CN102772449A Poria peel extract and application of poria peel extract in medicine for treating chronic renal failure |
11/14/2012 | CN102771791A Healthcare food and preparation method and application thereof |
11/14/2012 | CN102242043B Bo beer blending liquor and preparation method thereof |
11/14/2012 | CN102091263B Application of Chinese medicine composition in preparation of medicament for treating overhigh level of urine cell factor or receptor thereof and Escherichia coli infection |
11/14/2012 | CN101732562B Traditional Chinese medicine for tonifying kidneys, strengthening heart, dissipating blood stasis and activating collaterals |
11/14/2012 | CN101632780B Application of Chinese medicinal composition in preparing medicament for treating diabetic nephropathy |
11/14/2012 | CN101619062B Natural fibrauretine crystal and macroporous adsorbent resin preparation method thereof |
11/14/2012 | CN101309909B 2-phenylethylamino derivatives as calcium and/or sodium channel modulators |
11/13/2012 | US8309609 Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
11/08/2012 | US20120283309 Sirna compounds comprising terminal substitutions |
11/08/2012 | US20120283292 Fatty acid lenalidomide and their uses |
11/08/2012 | US20120283255 Urea derivatives, methods for their manufacture, and uses therefor |
11/08/2012 | US20120283234 Bile Acid Derivatives As FXR Ligands For The Prevention Or Treatment Of FXR-Mediated Diseases Or Conditions |
11/08/2012 | US20120283219 Diaminopteridine derivatives |
11/08/2012 | US20120283215 Pharmaceutical compositions which inhibit fkbp52-mediated regulation of androgen receptor function and methods of using same |
11/08/2012 | US20120283190 Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis |
11/08/2012 | US20120283187 Controlled release composition and method of producing the same |
11/08/2012 | US20120283169 Pharmaceutical composition, methods for treating and uses thereof |
11/08/2012 | US20120282350 Performance enhancing compositions and methods of use |
11/08/2012 | US20120282336 Bilayer tablet formulations |
11/08/2012 | US20120282332 Composition and method thereof |
11/08/2012 | US20120282252 5Imidazoquinolines and Pyrimidine Derivatives as Potent Modulators of VEGF-Driven Angiogenic Processes |
11/07/2012 | EP2520648A1 Anti-iga1 antibody |
11/07/2012 | EP2520589A1 Anti-cd27 antibody |
11/07/2012 | EP2519248A1 Methods for the prevention or treatment of vessel occlusion injury |
11/07/2012 | CN102764438A Novel application of beta3 adrenoceptor agonist |
11/07/2012 | CN102764420A Traditional Chinese medicine for treating urolithiasis and preparation and taking method thereof |
11/07/2012 | CN102764389A Traditional Chinese medicine granule for curing liver channel damp and hot infant enuresis |
11/07/2012 | CN102764367A Medicine composition for treating diabetes mellitus and complications |
11/07/2012 | CN102764360A Traditional Chinese medicine composition for treating acute cystitis |
11/07/2012 | CN102764338A Medicine composition for treating renal diseases |
11/07/2012 | CN102764311A Xiao Jin dispensible tablet and preparation method thereof |
11/07/2012 | CN102764246A Trospium chloride controlled release capsule and preparation method thereof |
11/07/2012 | CN102284026B Chinese medicine for treating hematuria |
11/07/2012 | CN102240370B Chinese medicinal composition for treating benign prostatic hyperplasia and preparation method thereof |
11/07/2012 | CN102145086B Plantago tonic decoction for treating chronic prostatitis |
11/07/2012 | CN102048699B Preparation method for sustained release microsphere of injection triptorelin acetate |
11/07/2012 | CN101991633B Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof |
11/07/2012 | CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
11/07/2012 | CN101590051B Drug combination containing nicotinic acid, HMG-CoA reductase inhibitor and alpha-glucosidase inhibitor |
11/06/2012 | US8304414 Pyrazole compounds useful as protein kinase inhibitors |
11/06/2012 | CA2661987C Process for the preparation of sevelamer hydrochloride and formulation thereof |
11/06/2012 | CA2551043C The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis and of acute or chronic kidney diseases |
11/06/2012 | CA2489208C Interleukin-6 suppressive agent |
11/06/2012 | CA2302743C Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
11/01/2012 | WO2012149083A1 Ppar-sparing thiazolidinediones for the treatment of kidney related diseases |
11/01/2012 | WO2012147901A1 Composition for mitigating anticancer drug side effects |
11/01/2012 | WO2012078736A9 Fibrinogen and kidney damage |
11/01/2012 | US20120277317 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-related diseases |
11/01/2012 | US20120277305 Fatty acid guanidine and salicylate guanidine derivatives and their uses |
11/01/2012 | US20120277303 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof |
11/01/2012 | US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal |
11/01/2012 | US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
11/01/2012 | US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes |
11/01/2012 | US20120277228 Novel Azaheterocyclic Compounds |
11/01/2012 | US20120277227 Benzimidazole inhibitors of leukotriene production |
11/01/2012 | US20120277226 Benzimidazole inhibitors of leukotriene production |
11/01/2012 | US20120277220 5 OXO-5,8-DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATIVES AS CAMKII KINASE INHIBITORS FOR TREATING CARDIOVASCULAR DISEASES |
11/01/2012 | US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof |
11/01/2012 | US20120277215 Organic Compounds |
11/01/2012 | US20120277205 Derivatives of n-[(1h-pyrazol-1-yl)aryl]-1h-indole or 1h-indazole-3-carboxamide, preparation thereof and applications thereof in therapeutics |
11/01/2012 | US20120277190 Prodrugs of compounds that inhibit trpv1 receptor |
11/01/2012 | US20120277183 Phosphate-binding chitosan and uses thereof |
11/01/2012 | US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
11/01/2012 | US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
11/01/2012 | US20120277155 Therapy for kidney disease and/or heart failure |
11/01/2012 | US20120276225 Phytoestrogenic nutraceutical composition from palm leaf extract |